Information Library
White Papers - Faster product development
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by:
- Most Recent
- Title
-
Mapping the Future in Oncology Drug Development
August 27, 2010
Industry veterans Harish Dave and Eric Groves summarize key findings of Quintiles’ ASCO Ancillary Event, Mapping the Future in Oncology Drug Development -
New York State's New PACeR Clinical Data Network
August 5, 2010
This briefing describes how the PACeR initiative has connected hospitals, physicians, patients' homes and pharmaceutical scientists to provide valuable insights into current, real-world medical practices. -
Managing Pharmacovigilance as a Business
July 28, 2010
The three steps required to develop a strategic approach to global capacity management. -
Challenges in Conducting Trials in Alzheimer's Disease
May 21, 2010
This paper examines the opportunities for conducting clinical trials in Alzheimer's disease in low and middle income countries. -
FDA Requirements for Clinical Studies in Pediatric Patients
April 1, 2010
FDA Requirements for Clinical Studies in Pediatric Patients FDA rules around pediatric drug trials have been tightening, to ensure more targeted data on drug efficacy -
Integration of Molecular Biomarkers into Clinical Development
March 29, 2010
Examining the challenges and opportunities in co-developing a biomarker and drug, this is the first white paper in a new series focusing on oncology. -
Data-Driven Patient Recruitment
March 23, 2010
Under pressure to deliver more evidence faster, drug developers are constantly searching for more patients for clinical trials. -
Regulations for Clinical Studies in Pediatric Patients in the European Union
March 10, 2010
After the United States issued pediatric drug study requirements, the European Union (EU) passed a regulation that created major changes to clinical studies for pediatric -
Key Trends in Multiple Myeloma Treatment
February 26, 2010
An overview of the latest studies into novel drug combinations and new therapies in early stage testing in multiple myeloma. -
Chasing Influenza
November 30, 2009
The rise in influenza strains like H1N1 — and the demand for new vaccines — signals a new era in vaccines. Learn how flu vaccines have evolved and where they’re headed.
